2 employees
Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.
2018
$496K
from 1 investors over 1 rounds
Ebumab ApS raised $496K on September 6, 2022
Investors: BioInnovation Institute